PATEN PRUITT: Open Payments
NPI 1730809799 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,752 in 132 payments from 21 companies in 2025. Trend: 2023 $1,711 · 2024 $2,323 · 2025 $2,752
Food & beverage: $2,752
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $875 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $301 |
| Janssen Biotech, Inc. | 8 | $188 |
| PFIZER INC. | 9 | $180 |
| Madrigal Pharmaceuticals | 6 | $169 |
| Celltrion USA Inc. | 7 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $140 |
| GENZYME CORPORATION | 6 | $132 |
| Lilly USA, LLC | 6 | $101 |
| Regeneron Healthcare Solutions, Inc. | 5 | $92 |
Products named: RINVOQ, ENTYVIO, TREMFYA, REZDIFFRA, DUPIXENT, SKYRIZI, VEGZELMA, XIFAXAN.
Industry payments across TN — which companies pay providers there.
